Emerging perspectives in cardiovascular medicine

[en] Cardiovascular medicine continues to evolve rapidly through advances in molecular biology, biomarkers, digital technologies, and interventional strategies. Recent contributions highlight progress in arrhythmia management, artificial intelligence-assisted diagnostics, metabolic and inflammatory risk stratification, and the understanding of rare cardiomyopathies. These developments illustrate the transition towards more precise and individualised cardiovascular care while raising new clinical and ethical challenges. Integrating technological innovation with clinical expertise remains essential to ensure that advances translate into improved patient outcomes.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Oury, Cécile ; Université de Liège - ULiège > GIGA > GIGA Metabolism & Cardiovascular Biology - Cardiology

Language :

English

Title :

Emerging perspectives in cardiovascular medicine

Publication date :

07 February 2026

Journal title :

Acta Cardiologica

ISSN :

0001-5385

eISSN :

1784-973X

Publisher :

Informa UK Limited

Volume :

Issue :

Pages :

123-127

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://www.tandfonline.com/doi/pdf/10.1080/00015385.2026.2645455

Available on ORBi :

since 22 July 2026

Statistics

Number of views

45 (0 by ULiège)

Number of downloads

51 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Lancellotti P, Cosyns B., Highlights of acta cardiologica. Acta Cardiol. 2022;77(6):469–470. doi: 10.1080/00015385.2022.2143092.
Lancellotti P, Oury C., Recent advances in cardiovascular medicine: from molecular mechanisms to precision care. Acta Cardiol. 2025;80(9):949–953. doi: 10.1080/00015385.2025.2579430.
Lancellotti P, Oury C., Advancing cardiovascular risk assessment and diagnostics. Acta Cardiol. 2025;80(2):105–108. doi: 10.1080/00015385.2025.2479954.
Lancellotti P, Oury C., Recent advances in cardiovascular pathophysiology, biomarkers, and therapeutic strategies: highlights from Acta Cardiologica. Acta Cardiol. 2025;80(8):767–773. doi: 10.1080/00015385.2025.2572167.
de Vries TAC, Hemels MEW, Cools F, et al.Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study. Acta Cardiol. 2021;76(4):431–439. doi: 10.1080/00015385.2020.1746095.
Wu J, Hou Q, Han Q, et al.Atrial fibrillation is an independent risk factor for new-onset myocardial infarction: a prospective study. Acta Cardiol. 2023;78(3):341–348. doi: 10.1080/00015385.2022.2129184.
Ku D, Lim HE, Park J, et al.Risk factors of failed electrical cardioversion in patients with persistent or long-standing persistent atrial fibrillation. Acta Cardiol. 2026;6:1–8. doi: 10.1080/00015385.2025.2611599.
Solak Y, Yılmaz MM, Karaarslan O, et al.Clinical implications of failed electrical cardioversion in long-standing persistent atrial fibrillation. Acta Cardiol. 2026;23:1–2. doi: 10.1080/00015385.2026.2633921.
Waranugraha Y, Rizal A, Yuniadi Y., The role of soluble ST2 in atrial fibrillation development and its recurrence after catheter ablation: a systematic review and meta-analysis study. Acta Cardiol. 2025;18:1–10. doi: 10.1080/00015385.2025.2554396.
Martens B, Duytschaever M., Early rhythm control in atrial fibrillation anno 2024. Acta Cardiol. 2024;79(10):1064–1070. doi: 10.1080/00015385.2024.2324217.
Schutyser W, Ector J, De Potter T, et al.Evaluation of pulsed-field ablation for paroxysmal atrial fibrillation: a systematic review. Acta Cardiol. 2025;7:1–15. doi: 10.1080/00015385.2025.2538384.
Palmisano P, Dell’Era G, Strangio A, et al.Conduction system pacing in the Italian clinical practice: results of a nationwide survey. Acta Cardiol. 2026;21:1–9. doi: 10.1080/00015385.2026.2617527.
Dujardin K, Vander Heyde L, Carlier S, et al.Belgian position paper on implementing artificial intelligence in cardiology: a roadmap from theory to clinical practice. Acta Cardiol. 2025;27:1–16.
Ferreira AS, Parisotto G., Insights from Ungureanu et al.: interpreting AI-clinician disagreement in ECG diagnostics. Acta Cardiol. 2026;12:1–3. doi: 10.1080/00015385.2026.2630134.
Ungureanu CM, Jossart A, Dadkhah R, et al.The first institutional survey on implementing an artificial intelligence application for ECG diagnostics: integration across medical specialties in routine clinical practice. Acta Cardiol. 2026;81(1):113–121. doi: 10.1080/00015385.2025.2611607.
van Lier R, Stuyck N, Poels P, et al.Attitudes of patients, relatives and professionals regarding deactivation of implantable cardioverter-defibrillators: a scoping review. Acta Cardiol. 2026;27:1–23. doi: 10.1080/00015385.2026.2620233.
Lancellotti P, De La Brassinne Bonardeaux O., Biomarkers and inflammation in coronary artery disease: key insights. Acta Cardiol. 2024;79(7):747–750. doi: 10.1080/00015385.2024.2421090.
Zwaenepoel B, Dhont S, Schaubroeck H, et al.The use of cardiac troponins and B-type natriuretic peptide in COVID-19. Acta Cardiol. 2022;77(7):567–572. doi: 10.1080/00015385.2021.1970403.
Aker M, Kalçık M, Bekar L., Interpreting triglyceride–glucose index and high-sensitivity C-reactive protein interactions in post-PCI cardiovascular risk prediction. Acta Cardiol. 2026;9:1–2. doi: 10.1080/00015385.2025.2611597.
Sun W, Sun W, Zhao X, et al.Predictive value of the triglyceride-glucose index combined with inflammatory markers for major adverse cardiovascular events after PCI. Acta Cardiol. 2025;27:1–15.
Gürses E, Yapan Emren Z, Sivri F., Assessment of the relationship between J-CTO score and Triglyceride-Glucose index in patients with chronic total occlusion. Acta Cardiol. 2026;10:1–6. doi: 10.1080/00015385.2026.2626609.
Dongsheng C, Zhang X, Yang D., Dysregulation of serum hsa_circ_0005870 serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients. Acta Cardiol. 2026;5:1–11.
Yetim M, Kalçık M., Coronary calcium scoring and risk prediction in heterozygous familial hypercholesterolemia. Acta Cardiol. 2026;11:1–2. doi: 10.1080/00015385.2026.2630546.
Ernaga Lorea A, Apellaniz Ruiz M, Martinez de Esteban JP, et al.Assessment of subclinical atherosclerosis with coronary calcium score in heterozygous familial hypercholesterolemia. Acta Cardiol. 2026;81(1):94–101. doi: 10.1080/00015385.2025.2597126.
Reskovic Luksic V, Petkovic Ramadza D, Separovic Hanzevacki J., Fabry disease in women: still hidden or overlooked diagnosis?Acta Cardiol. 2025;4:1–3. doi: 10.1080/00015385.2025.2554393.
Côté M-A, Barde L, Voisine É, et al.Cardiac manifestations of Fabry disease: are women getting enough attention?Acta Cardiol. 2025;27:1–8. doi: 10.1080/00015385.2025.2576432.
de Marneffe N, Dulgheru R, Ancion A, et al.Cardiac amyloidosis: a review of the literature. Acta Cardiol. 2022;77(8):683–692. doi: 10.1080/00015385.2021.1992990.
Khan AA, Faheem MSB, Wahid F, et al.Role SGLT2 inhibitor therapy in patients with transthyretin cardiac amyloidosis: a GRADE assessed systematic review and meta-analysis. Acta Cardiol. 2025;5:1–9. doi: 10.1080/00015385.2025.2594908.
Humbert X, Licaj I, Fedrizzi S, et al.Relationship between lifestyle factors and hypertension: a cross-sectional analysis from the Gubbio study. Acta Cardiol. 2023;78(5):565–573. doi: 10.1080/00015385.2022.2088170.
Menotti A, Puddu PE, Catasta G., Lifestyle behaviours predicting major cardiovascular diseases mortality in a practically extinct cohort of middle-aged men followed-up for 61 years. Acta Cardiol. 2023;78(5):578–585. doi: 10.1080/00015385.2022.2101876.
Kulthamrongsri N, Sripusanapan A, Suenghataiporn T, et al.Sleep duration ratio, a novel parameter associated with a reduced risks of coronary artery disease and myocardial infarction: findings from NHANES 2017-2023. Acta Cardiol. 2026;13:1–8. doi: 10.1080/00015385.2025.2601924.
Chen H, Deng C, Xiong X, et al.Double balloon technique for vein of Marshall ethanol infusion. Acta Cardiol. 2026;20:1. doi: 10.1080/00015385.2025.2605373.
Mannion J, Prendiville T, Murphy K, et al.Regression of massive left ventricular hypertrophy in Danon disease. Acta Cardiol. 2026;10:1–2. doi: 10.1080/00015385.2026.2626613.
Karakulak UN, Ardali Duzgun S, Kuyugoz G, et al.When four become two: a quadricuspid aortic valve functioning as a bicuspid valve. Acta Cardiol. 2026;9:1–4. doi: 10.1080/00015385.2026.2625907.
Mufti G, Ahmed AS., Cardiac metastasis in squamous cell carcinoma of tongue. Acta Cardiol. 2026;30:1–2. doi: 10.1080/00015385.2026.2620850.
Kardos M., Cor triatriatum and partial anomalous venous drainage. Acta Cardiol. 2026;23:1–1. doi: 10.1080/00015385.2026.2617561.
Gurjar NK, Singh R, Jain C., Fatal giant left ventricular aneurysm with massive intraluminal thrombus: a rare and catastrophic presentation. Acta Cardiol. 2026;14:1–3. doi: 10.1080/00015385.2026.2614654.
Chen D, Wang L, Ma X, et al.Imaging of a rare left ventricular intramyocardial lipoma. Acta Cardiol. 2026;13:1. doi: 10.1080/00015385.2025.2611493.